CARDIOVASCULAR DISEASE IN COVID-19 PATIENTS. PART 1
Journal: Journal of the Grodno State Medical University (Vol.18, No. 6)Publication Date: 2020-12-31
Authors : Holyshko V. S.; Snezhitskiy V. A.; Matsiyeuskaya N. V.;
Page : 643-647
Keywords : coronavirus SARS-CoV-2; myocardial damage; pathology of the cardiovascular system;
Abstract
The COVID-19 pandemic caused by SARS-CoV-2 is the greatest medical problem of our time. The presence of concomitant cardiovascular pathology in a patient predisposes to a severe course and the formation of adverse outcomes of COVID-19. It is currently known that SARS-CoV-2 infection leads, on the one hand, to exacerbation and decompensation of the patient's cardiovascular disease, on the other hand, it is the origin of acute cardiovascular pathology. Understanding the impact of COVID-19 on the cardiovascular system is essential for providing comprehensive care to critically ill patients. In this review, we summarize the rapidly changing data on cardiovascular damage associated with COVID-19.
Other Latest Articles
- Another Successful Application of Newly Prepared GO-SiC3-NH3-H2PW as Highly Efficient Nanocatalyst for Fast Synthesis of Tetrahydrobenzo[b]pyrans
- Green and Easy Synthesis of Xanthenes Using Formic Acid as Bio-Based and Green Catalyst under Solvent-Free Conditions
- Synthesis, Solubility in Various Solvents, Spectroscopic Properties (FT–IR, 1H, 13C and 15N–NMR, UV–Vis), NBO, NLO, FMO Analysis of A MNDPPD Drug
- Preparation and Comparison of Two Different Nanocomposite Kinds Based on MgZnAl-Layered Double Hydroxide for Simultaneous Removal of Cationic and Anionic Dyes
- Electrochemical Sensing of Thioridazine in Human Serum Samples Using Modified Glassy Carbon Electrode
Last modified: 2021-01-26 16:02:15